Europe — EMA

Palexia Retard (Tapentadol)

Tapentadol, the active ingredient in Palexia Retard, is an opioid analgesic presented as a unknown strength/unknown form for oral use.

Tapentadol

Request sourcing

Pack/s

What is Tapentadol?

Tapentadol, the active ingredient in Palexia Retard, is an opioid analgesic presented as a unknown strength/unknown form for oral use. It treats moderate to severe chronic pain in adult patients when other analgesics are insufficient.

GNH USA supplies Palexia Retard as a licensed ...

What is Tapentadol used for?

...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →